価格表

在庫・価格 : 2024年05月30日 00時06分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SARS-CoV-2 (COVID-19) Spike S1, Rabbit-Mono(HL6)
データシート
GTX635654 GNTジーンテックス
GeneTex International Corporation
100 μl ¥75,000 1個 追加

在庫・価格 : 2024年05月30日 00時06分 現在

Anti-SARS-CoV-2 (COVID-19) Spike S1, Rabbit-Mono(HL6)

  • 商品コード:GTX635654
  • メーカー:GNT
  • 包装:100μl
  • 価格: ¥75,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Manト稿k-Keber M et al. Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. FASEB J 2021 06;35(6):e21651
Manト稿k-Keber M et al
2021/01/01
PubMed
2 Motozono C et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe 2021 07;29(7):1124-1136.e11
Motozono C et al
2021/01/01
PubMed
3 Danics K et al. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. Geroscience 2021 10;43(5):2265-2287
Danics K et al
2021/01/01
PubMed
4 Song Z et al. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients. Signal Transduct Target Ther 2022 01;7(1):29
Song Z et al
2022/01/01
PubMed
5 Park SB et al. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. mBio 2022 Jan;:e0323821
Park SB et al
2022/01/01
PubMed
6 Saito A et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature 2022 02;602(7896):300-306
Saito A et al
2022/01/01
PubMed
7 Kim HK et al. Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection. Biomaterials 2022 Apr;283:121460
Kim HK et al
2022/01/01
PubMed
8 Chen Y et al. Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva. Res Sq 2021 Jan;
Chen Y et al
2021/01/01
PubMed
9 Reagan-Steiner S et al. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta. Emerg Infect Dis 2022 Mar;28(3):510-517
Reagan-Steiner S et al
2022/01/01
PubMed
10 Deng W et al. Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques. Signal Transduct Target Ther 2022 Apr;7(1):124
Deng W et al
2022/01/01
PubMed
11 Chen Y et al. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Sci Adv 2022 May;8(21):eabn3481
Chen Y et al
2022/01/01
PubMed
12 T Iida et al., High-throughput Light-induced Immunoassay under One-minute Antibody-coating with Energy Saving Nanoparticle-imprinted Substrate, Research Square., 2024., ().,

PubMed
13 Miura K et al. Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells. J Virol 2023 Oct;97(10):e0042623
Miura K et al
2023/01/01
PubMed
14 Di Primio C et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus 2023 Sep;2(9):pgad282
Di Primio C et al
2023/01/01
PubMed
15 Liu JF et al. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice. EBioMedicine 2023 Apr;90:104518
Liu JF et al
2023/01/01
PubMed
16 Piranej S et al. Rolosense: Mechanical detection of SARS-CoV-2 using a DNA-based motor. bioRxiv 2023 Feb;
Piranej S et al
2023/01/01
PubMed
17 Reyes S et al. Metal organic framework encapsulated tamavidin-Gluc reporter: application in COVID-19 spike antigen bioluminescent immunoassay. Sens Diagn 2022 Nov;1(6):1198-1208
Reyes S et al
2022/01/01
PubMed
18 Padula L et al. Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses. Vaccine X 2022 Dec;12:100202
Padula L et al
2022/01/01
PubMed
19 Chuang HC et al. SARS-CoV-2 spike protein enhances MAP4K3/GLK-induced ACE2 stability in COVID-19. EMBO Mol Med 2022 Sep;14(9):e15904
Chuang HC et al
2022/01/01
PubMed
20 Nasser H et al. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay. STAR Protoc 2022 Dec;3(4):101773
Nasser H et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Manト稿k-Keber M et al. Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. FASEB J 2021 06;35(6):e21651
    Manト稿k-Keber M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Motozono C et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe 2021 07;29(7):1124-1136.e11
    Motozono C et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Danics K et al. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. Geroscience 2021 10;43(5):2265-2287
    Danics K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Song Z et al. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients. Signal Transduct Target Ther 2022 01;7(1):29
    Song Z et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Park SB et al. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. mBio 2022 Jan;:e0323821
    Park SB et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Saito A et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature 2022 02;602(7896):300-306
    Saito A et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kim HK et al. Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection. Biomaterials 2022 Apr;283:121460
    Kim HK et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chen Y et al. Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva. Res Sq 2021 Jan;
    Chen Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Reagan-Steiner S et al. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta. Emerg Infect Dis 2022 Mar;28(3):510-517
    Reagan-Steiner S et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Deng W et al. Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques. Signal Transduct Target Ther 2022 Apr;7(1):124
    Deng W et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Chen Y et al. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Sci Adv 2022 May;8(21):eabn3481
    Chen Y et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    T Iida et al., High-throughput Light-induced Immunoassay under One-minute Antibody-coating with Energy Saving Nanoparticle-imprinted Substrate, Research Square., 2024., ().,

  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Miura K et al. Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells. J Virol 2023 Oct;97(10):e0042623
    Miura K et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Di Primio C et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus 2023 Sep;2(9):pgad282
    Di Primio C et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Liu JF et al. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice. EBioMedicine 2023 Apr;90:104518
    Liu JF et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Piranej S et al. Rolosense: Mechanical detection of SARS-CoV-2 using a DNA-based motor. bioRxiv 2023 Feb;
    Piranej S et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Reyes S et al. Metal organic framework encapsulated tamavidin-Gluc reporter: application in COVID-19 spike antigen bioluminescent immunoassay. Sens Diagn 2022 Nov;1(6):1198-1208
    Reyes S et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Padula L et al. Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses. Vaccine X 2022 Dec;12:100202
    Padula L et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Chuang HC et al. SARS-CoV-2 spike protein enhances MAP4K3/GLK-induced ACE2 stability in COVID-19. EMBO Mol Med 2022 Sep;14(9):e15904
    Chuang HC et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Nasser H et al. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay. STAR Protoc 2022 Dec;3(4):101773
    Nasser H et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed